TY - JOUR
T1 - Spine stereotactic body radiation therapy plans
T2 - Achieving dose coverage, conformity, and dose falloff
AU - Hong, Linda X.
AU - Shankar, Viswanathan
AU - Shen, Jin
AU - Kuo, Hsiang Chi
AU - Mynampati, Dinesh
AU - Yaparpalvi, Ravindra
AU - Goddard, Lee
AU - Basavatia, Amar
AU - Fox, Jana
AU - Garg, Madhur
AU - Kalnicki, Shalom
AU - Tomé, Wolfgang A.
N1 - Publisher Copyright:
© 2015 American Association of Medical Dosimetrists.
PY - 2015/2/3
Y1 - 2015/2/3
N2 - We report our experience of establishing planning objectives to achieve dose coverage, conformity, and dose falloff for spine stereotactic body radiation therapy (SBRT) plans. Patients with spine lesions were treated using SBRT in our institution since September 2009. Since September 2011, we established the following planning objectives for our SBRT spine plans in addition to the cord dose constraints: (1) dose coverage-prescription dose (PD) to cover at least 95% planning target volume (PTV) and 90% PD to cover at least 99% PTV; (2) conformity index (CI)-ratio of prescription isodose volume (PIV) to the PTV < 1.2; (3) dose falloff-ratio of 50% PIV to the PTV (R50%); (4) and maximum dose in percentage of PD at 2cm from PTV in any direction (D2cm) to follow Radiation Therapy Oncology Group (RTOG) 0915. We have retrospectively reviewed 66 separate spine lesions treated between September 2009 and December 2012 (31 treated before September 2011 [group 1] and 35 treated after [group 2]). The χ2 test was used to examine the difference in parameters between groups. The PTV V100% PD ≥ 95% objective was met in 29.0% of group 1 vs 91.4% of group 2 (p < 0.01) plans. The PTV V90% PD ≥ 99% objective was met in 38.7% of group 1 vs 88.6% of group 2 (p < 0.01) plans. Overall, 4 plans in group 1 had CI > 1.2 vs none in group 2 (p = 0.04). For D2cm, 48.3% plans yielded a minor violation of the objectives and 16.1% a major violation for group 1, whereas 17.1% exhibited a minor violation and 2.9% a major violation for group 2 (p < 0.01). Spine SBRT plans can be improved on dose coverage, conformity, and dose falloff employing a combination of RTOG spine and lung SBRT protocol planning objectives.
AB - We report our experience of establishing planning objectives to achieve dose coverage, conformity, and dose falloff for spine stereotactic body radiation therapy (SBRT) plans. Patients with spine lesions were treated using SBRT in our institution since September 2009. Since September 2011, we established the following planning objectives for our SBRT spine plans in addition to the cord dose constraints: (1) dose coverage-prescription dose (PD) to cover at least 95% planning target volume (PTV) and 90% PD to cover at least 99% PTV; (2) conformity index (CI)-ratio of prescription isodose volume (PIV) to the PTV < 1.2; (3) dose falloff-ratio of 50% PIV to the PTV (R50%); (4) and maximum dose in percentage of PD at 2cm from PTV in any direction (D2cm) to follow Radiation Therapy Oncology Group (RTOG) 0915. We have retrospectively reviewed 66 separate spine lesions treated between September 2009 and December 2012 (31 treated before September 2011 [group 1] and 35 treated after [group 2]). The χ2 test was used to examine the difference in parameters between groups. The PTV V100% PD ≥ 95% objective was met in 29.0% of group 1 vs 91.4% of group 2 (p < 0.01) plans. The PTV V90% PD ≥ 99% objective was met in 38.7% of group 1 vs 88.6% of group 2 (p < 0.01) plans. Overall, 4 plans in group 1 had CI > 1.2 vs none in group 2 (p = 0.04). For D2cm, 48.3% plans yielded a minor violation of the objectives and 16.1% a major violation for group 1, whereas 17.1% exhibited a minor violation and 2.9% a major violation for group 2 (p < 0.01). Spine SBRT plans can be improved on dose coverage, conformity, and dose falloff employing a combination of RTOG spine and lung SBRT protocol planning objectives.
KW - Spine SBRT plans
UR - http://www.scopus.com/inward/record.url?scp=84939466990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939466990&partnerID=8YFLogxK
U2 - 10.1016/j.meddos.2014.11.002
DO - 10.1016/j.meddos.2014.11.002
M3 - Article
C2 - 25498838
AN - SCOPUS:84939466990
SN - 0958-3947
VL - 40
SP - 181
EP - 185
JO - Medical Dosimetry
JF - Medical Dosimetry
IS - 3
ER -